Brachytherapy for targeting the immune system in cervical cancer patients.

Isabel Linares,Miguel Ángel Berenguer Frances,Rut Cañas,Dina Najjari,Cristina Gutiérrez,Susanna Marín, Silvia Comas,Ferran Guedea, Monica Pujol

BMC immunology（2023）

引用 0|浏览7

暂无评分

摘要

Immune biomarkers are important predictive determinants in cervical cancer. Higher cytotoxic NK cells and a trend toward lower values of Tregs might support the use of HDR-BT to the detriment of PDR-BT and help develop effective combinations with immunotherapy.

查看译文

关键词

cervical cancer,cervical cancer patients,cancer patients,immune system

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要